tradingkey.logo
tradingkey.logo
Buscar

Quipt Home Medical Corp

QIPT
Añadir a la lista de seguimiento
3.650USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
161.15MCap. mercado
PérdidaP/E TTM

Más Datos de Quipt Home Medical Corp Compañía

Quipt Home Medical Corp. provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. The Company's expertise spans across a full spectrum of respiratory care, providing an end-to-end solution for medical providers and patients. This includes technology enabled equipment offerings and specialized care for patients with cardio and pulmonary diseases, sleep disorders, mobility challenges, and other chronic disease management. The Company's healthcare products and services include sleep apnea and pap treatment, home medical equipment, home ventilation and custom mobility solutions. It has a 60% ownership interest in Hart Medical Equipment, which maintains strategic relationships with integrated health systems and freestanding community-based hospitals, embedding the business into the hospital discharge processes of more than 19 hospitals and affiliated care facilities across its network.

Información de Quipt Home Medical Corp

Símbolo de cotizaciónQIPT
Nombre de la empresaQuipt Home Medical Corp
Fecha de salida a bolsaMar 18, 2014
Director ejecutivoCrawford (Gregory)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 18
Dirección1019 Town Drive
CiudadWILDER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal41076
Teléfono18598782220
Sitio Webhttps://quipthomemedical.com/
Símbolo de cotizaciónQIPT
Fecha de salida a bolsaMar 18, 2014
Director ejecutivoCrawford (Gregory)

Ejecutivos de Quipt Home Medical Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Hardik Mehta
Mr. Hardik Mehta
Chief Financial Officer
Chief Financial Officer
1.04M
-11.78%
Mr. Mark Miles
Mr. Mark Miles
Chief Compliance Officer
Chief Compliance Officer
110.00K
--
Mr. Patrick Gamble
Mr. Patrick Gamble
Executive Vice President - Operations
Executive Vice President - Operations
60.06K
+33.30%
Mr. Gregory (Greg) Crawford
Mr. Gregory (Greg) Crawford
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Mark Greenberg
Mr. Mark Greenberg
Independent Director
Independent Director
--
--
Dr. Kevin A. Carter
Dr. Kevin A. Carter
Independent Director
Independent Director
--
--
Mr. Brian J. Wessel
Mr. Brian J. Wessel
Independent Director
Independent Director
--
--
Mr. Thomas W. Roehrig
Mr. Thomas W. Roehrig
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. David Bachelder
Mr. David Bachelder
Executive Vice President - Operations
Executive Vice President - Operations
--
--
Mr. Cole Stevens
Mr. Cole Stevens
Vice President - Corporate Development
Vice President - Corporate Development
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Hardik Mehta
Mr. Hardik Mehta
Chief Financial Officer
Chief Financial Officer
1.04M
-11.78%
Mr. Mark Miles
Mr. Mark Miles
Chief Compliance Officer
Chief Compliance Officer
110.00K
--
Mr. Patrick Gamble
Mr. Patrick Gamble
Executive Vice President - Operations
Executive Vice President - Operations
60.06K
+33.30%
Mr. Gregory (Greg) Crawford
Mr. Gregory (Greg) Crawford
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Mark Greenberg
Mr. Mark Greenberg
Independent Director
Independent Director
--
--
Dr. Kevin A. Carter
Dr. Kevin A. Carter
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Quipt Home Medical Corp?

Los cinco principales accionistas de Quipt Home Medical Corp son: Mr. Hardik Mehta

¿Cuántas instituciones poseen acciones de Quipt Home Medical Corp (QIPT)?

A fecha de 2025Q4, 192 instituciones poseen acciones de Quipt Home Medical Corp, con un valor de mercado combinado de aproximadamente 23.43M, lo que representa el 53.22% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -5372480.00.